CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
53
RYTM Quote, Financials, Valuation and Earnings
Last price:
$64.63
Seasonality move
:
14.49%
Day range:
$61.48 - $64.24
52-week range:
$35.17 - $68.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
29.39x
P/B ratio:
183.54x
Volume:
828K
Avg. volume:
840K
1-year change:
42.91%
Market cap:
$4B
Revenue:
$130.1M
EPS (TTM):
-$4.35
Rhythm Pharmaceuticals Number of Institutional Trades
Rhythm Pharmaceuticals Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$3B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$3.6B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Rhythm Pharmaceuticals Institutional Ownership
-
What Percentage Of RYTM Is Owned by Institutions?
-- of RYTM is owned by institutions.
-
How Many Institutions Own RYTM Shares?
Rhythm Pharmaceuticals stock is owned by 441 institutional shareholders at this time.
-
Have Institutions Been Buying RYTM Stock?
Yes, institutions have bought 30M shares of RYTM in the last quarter.
-
Have Institutions Been Selling RYTM Stock?
Yes, institutions have sold 37.9M shares of RYTM over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
